Category: Regulations
-
Brain Cancer Regression Shown with Engineered T-Cells
A patient treated with immune system cells genetically modified to attack his brain cancer reported regression of recurring tumors in the brain and spinal cord.
-
FDA Approves Spinal Muscular Atrophy Drug [Updated]
A drug to treat spinal muscular atrophy, a genetic disorder causing the wasting away of muscle tissue in children and adults, was approved for sale in the U.S.
-
Smartphone System Shown to Control Blood Glucose Levels
A bionic pancreas system using a smartphone was shown in a clinical trial to control blood glucose levels better than a commercial insulin pump in persons with type 1 diabetes.
-
New Type of Antibiotic Set for Early Trial
A clinical trial is set to test a type of drug that its developers say is designed to treat infections from bacteria resistant to earlier antibiotics.
-
Trial to Explore Microbiome Therapy for Hypertension
A clinical trial is set to begin that tests live bacteria as a treatment for hypertension, or high blood pressure, a condition affecting 1 in 3 adults in the U.S.
-
Trial Testing Stem-Cell Implant for Cartilage Repair
An early clinical trial testing implants of a person’s stem cells to repair damaged knee cartilage in younger adults returned largely favorable results.
-
Trial to Test Radio Waves to Treat Alzheimer’s
A clinical trial is inviting individuals with Alzheimer’s disease to test a device that its designers claim can reverse cognitive impairment resulting from Alzheimer’s disease.
-
Many Health Apps Found Not Helping People in Need
Many mobile apps designed to help manage one’s health are not assisting people in most need of that help and often do not appropriately respond to information with dangerous consequences.
-
High Leukemia Remissions Reported for Engineered T-Cells
First results from an international clinical trial of engineered immune system cells to treat leukemia in children show high rates of remission, but also many severe adverse effects.
-
Stem Cell Therapy Shows Early Results with Multiple Myeloma
First results from an early clinical trial show some patients with multiple myeloma receiving replacement blood-forming stem cells achieved at least a partial response and did not suffer severe adverse effects.